Altimmune’s latest earnings call struck an upbeat tone, with management leaning on robust Phase II liver data, a coveted FDA Breakthrough Therapy designation, and a fortified balance sheet that ...
Pembroke VCT ( (GB:PEMB)) has issued an update. Pembroke VCT plc has confirmed that as of 31 December 2025 its issued share capital comprises 272,885,612 B Ordinary shares, all of which carry voting ...
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private investor ...
Pembroke VCT plc (the "Company") has today published a prospectus (the "Prospectus") in relation to the offer for subscription of up to £40 million of B Ordinary Shares of 1p each in the capital of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results